Cargando…

High-dose methotrexate vs. Capizzi methotrexate for the treatment of childhood T-cell acute lymphoblastic leukemia

Sixty-three children (1–14 years of age) newly diagnosed with T-cell acute lymphoblastic leukemia were treated from January 2001 to December 2014. Patient outcomes were evaluated based on the regimen received; Capizzi methotrexate (C-MTX) vs. high-dose methotrexate (HDMTX). Complete remission (CR) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jastaniah, Wasil, Elimam, Naglla, Abdalla, Khalid, AlAzmi, Aeshah A., Aseeri, Mohammed, Felimban, Sami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215054/ https://www.ncbi.nlm.nih.gov/pubmed/30416957 http://dx.doi.org/10.1016/j.lrr.2018.10.001

Ejemplares similares

Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia
por: Jastaniah, Wasil, et al.
Publicado: (2018)

A Retrospective Single-Center Study of Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Children With Tumor Lysis Syndrome
por: Al Blewi, Sawsan M, et al.
Publicado: (2023)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017)

The prognostic significance of hypertension at diagnosis in children with wilms tumor
por: Jastaniah, Wasil, et al.
Publicado: (2017)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
por: Abedi, Marjan, et al.
Publicado: (2020)

The Characteristics and Follow-Up of SARS-CoV-2 Infection in Pediatric Oncology Patients
por: Alkharouby, Raghad, et al.
Publicado: (2023)

Mercaptopurine/Methotrexate Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia: Clinical Facts and Fiction
por: Schmiegelow, Kjeld, et al.
Publicado: (2014)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
por: Xu, Meng, et al.
Publicado: (2022)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Case report: Intravitreal methotrexate in intraocular acute lymphoblastic leukemia
por: Pederzolli, Matteo, et al.
Publicado: (2022)

Methotrexate-Mediated Arachnoiditis in a Child with Acute Lymphoblastic Leukemia
por: Karamercan, Sırma, et al.
Publicado: (2022)

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report
por: Maya Naranjo, Maria Isabel, et al.
Publicado: (2023)

Unilateral Cytomegalovirus Retinitis in a Child With Acute Lymphoblastic Leukemia While on Maintenance Chemotherapy
por: Mandura, Rahaf A, et al.
Publicado: (2021)

Efficacy and association analysis of high-dose methotrexate in the treatment of children with acute lymphoblastic leukemia
por: Gong, Fangwei, et al.
Publicado: (2019)

High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
por: Zhang, Yazhi, et al.
Publicado: (2020)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
por: Jacob, Linu A., et al.
Publicado: (2015)

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
por: García-Cañaveras, Juan C., et al.
Publicado: (2020)

Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022)

Association of ABCC2 −24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
por: Liu, Yan, et al.
Publicado: (2014)

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2020)

Identifying risk factors for high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia
por: Li, Xiao, et al.
Publicado: (2019)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen, Yaqing, et al.
Publicado: (2021)

Intrathecal Methotrexate-Induced Aseptic Meningitis in a Patient with Acute Lymphoblastic Leukemia
por: Tang, Wesley, et al.
Publicado: (2022)

Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines
por: Canevarolo, Rafael Renatino, et al.
Publicado: (2022)

The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia
por: Samii, Bahareh, et al.
Publicado: (2023)

Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia
por: Esmaili, Mohammad Ali, et al.
Publicado: (2020)

Methotrexate-associated toxicity in children with Down syndrome and acute lymphoblastic leukemia during consolidation therapy with high dose methotrexate according to ALL-BFM treatment regimen
por: Kroll, Mirko, et al.
Publicado: (2020)

Correction: Association of ABCC2 -24C>T Polymorphism with High-Dose Methotrexate Plasma Concentrations and Toxicities in Childhood Acute Lymphoblastic Leukemia
Publicado: (2014)

Serum methotrexate in childhood ALL.
por: Cosolo, W., et al.
Publicado: (1992)

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
por: Pearson, A. D., et al.
Publicado: (1991)

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023)

Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia
por: Bartholomew, Joy L., et al.
Publicado: (2018)

Effect of serum albumin level on high-dose methotrexate induced toxicities in acute lymphoblastic leukemia patients
por: Mirza, Mehdi Ali, et al.
Publicado: (2023)

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2018)

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
por: Kotur, Nikola, et al.
Publicado: (2020)

Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia
por: Teshima, Kazuaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sq801dogkcq47tskukvboh2uoc